Pfizer will pay $59.7 million to resolve charges that a company it acquired defrauded Medicare and other healthcare programs ...

The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks so ...

New study reveals how Atogepant prevents migraines and reduces rebound headaches in chronic sufferers, offering hope for ...

A newly approved drug, atogepant, may start reducing migraines on the very first day ... a neurologist at Albert Einstein College of Medicine in New York, emphasized the importance of creating ...

CNX Therapeutics partners with Klaria Pharma to market sumatriptan alginate film in Europe, addressing critical migraine ...

Amitriptyline has long been used for migraine prevention. Discover how this antidepressant works, its side effects, and why it's still being prescribed.

How should she be evaluated and treated? What is the probable migraine type and the drug of choice for its treatment and long-term management?

Ibuprofen Plus Triptan for Migraine Relief Ibuprofen Plus Antiemetic for Migraine Relief. For those who experience migraine ...

Migraine is a common neurological syndrome that affects approximately 10–20% of the population. The pathophysiology of migraine is unclear. 5-hydroxytriptamine is a key mediator in the ...

If the FDA does approve the drug, ubrogepant will however have to compete head-to-head against Eli Lilly’s new acute migraine drug Reyvow (lasmiditan), a first-in-class serotonin 5-HT1F receptor ...

“With many current drugs to prevent migraine, it takes time to find the right dosage for the individual and it can take weeks or even months for it to be most effective,” said study author Richard B.